SARS-COV-2 Spike Glycoprotein as Inhibitory Target for Insilico Screening of Natural Compounds
Abstract Coronavirius disease 2019 (Covid-19) pandemic caused by SARS-Cov-2 has raised global health concern without approved drug for management of this lie threatening disease. The aim of this study was to predict the inhibitory potential of quercetin-3-o-rutinoside against SARS-Cov-2 spike glycoprotein. Targeting the SARS-Cov-2 spike protein from angiotensin converting enzyme 2 complex (pdb: 6lzg) is gaining importance. In this study, in silico computational relationship between plant-derived natural drug and spike glycoprotein was predicted. The results were evaluated based on glide (Schrodinger) dock score. Among the five (5) screened compounds, quercetin-3-o-rutinoside has the best docking score (-9.296) with the target. Molecular dynamic (MD) simulation study was performed for 1000ps to confirm the stability behavior of the spike protein and quercetin-3-o-rutinoside complex. The MD simulation study validated the stability of quercetin-3-o-rutinoside in the spike protein binding pocket as potent inhibitor..
Medienart: |
Preprint |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
ResearchSquare.com - (2021) vom: 17. März Zur Gesamtaufnahme - year:2021 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Omoboyowa, Damilola Alex [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
doi: |
10.21203/rs.3.rs-271483/v1 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
XRA034163913 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | XRA034163913 | ||
003 | DE-627 | ||
005 | 20230429184149.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220113s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.21203/rs.3.rs-271483/v1 |2 doi | |
035 | |a (DE-627)XRA034163913 | ||
035 | |a (ResearchSquare)10.21203/rs.3.rs-271483/v1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 570 |q DE-84 | |
100 | 1 | |a Omoboyowa, Damilola Alex |e verfasserin |4 aut | |
245 | 1 | 0 | |a SARS-COV-2 Spike Glycoprotein as Inhibitory Target for Insilico Screening of Natural Compounds |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract Coronavirius disease 2019 (Covid-19) pandemic caused by SARS-Cov-2 has raised global health concern without approved drug for management of this lie threatening disease. The aim of this study was to predict the inhibitory potential of quercetin-3-o-rutinoside against SARS-Cov-2 spike glycoprotein. Targeting the SARS-Cov-2 spike protein from angiotensin converting enzyme 2 complex (pdb: 6lzg) is gaining importance. In this study, in silico computational relationship between plant-derived natural drug and spike glycoprotein was predicted. The results were evaluated based on glide (Schrodinger) dock score. Among the five (5) screened compounds, quercetin-3-o-rutinoside has the best docking score (-9.296) with the target. Molecular dynamic (MD) simulation study was performed for 1000ps to confirm the stability behavior of the spike protein and quercetin-3-o-rutinoside complex. The MD simulation study validated the stability of quercetin-3-o-rutinoside in the spike protein binding pocket as potent inhibitor. | ||
700 | 1 | |a A, Balogun Toheeb |e verfasserin |4 aut | |
700 | 1 | |a Chukwudozie, Onyeka S. |e verfasserin |4 aut | |
700 | 1 | |a Nweze, Victor N. |e verfasserin |4 aut | |
700 | 1 | |a Saibu, Oluwatosin A. |e verfasserin |4 aut | |
700 | 1 | |a Abdulahi, Alausa |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t ResearchSquare.com |g (2021) vom: 17. März |
773 | 1 | 8 | |g year:2021 |g day:17 |g month:03 |
856 | 4 | 0 | |u http://dx.doi.org/10.21203/rs.3.rs-271483/v1 |z kostenfrei |3 Volltext |
912 | |a GBV_XRA | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |j 2021 |b 17 |c 03 | ||
953 | |2 045F |a 570 |